Results 81 to 90 of about 239,525 (205)

Prevention of Meningococcal Disease: Knowledge, Attitudes, and Practices of General Practitioners and Primary Care Pediatricians in South Italy

Vaccines
Background: The purpose of this study was to evaluate the knowledge, attitude, and current practices about prevention of meningococcal disease among general practitioners (GPs) and primary care pediatricians (PCPs) in Italy.
Silvia Angelillo, Concetta Paola Pelullo, Francesca Licata, Raffaele Lanzano, Francesco Napolitano, Gabriella Di Giuseppe   +5 more
doaj   +1 more source

ACIP Meningococcal Vaccines Work Group Introduction [PDF]

01-Meningococcal-Poehling-508 ...

core  

Meningococcal vaccines.

Current opinion in investigational drugs (London, England : 2000), 2003
Neisseria meningitidis is one of the leading infectious causes of death in children under five years old in industrialized countries, and most cases can be attributed to five disease-causing serogroups: A, B, C, Y and W135. Meningococcal vaccine development began in the 1930s with killed whole-cell and exotoxin vaccines, but widespread use of ...
Collins, C, Pollard, A
openaire   +4 more sources

Serogroup B meningococcal vaccines booster doses : Work Group interpretation, considerations for policy options, and next steps [PDF]

Meningococcal-5-Mbaeyi-508 ...

core  

Molecular epidemiology of meningococcal disease in Northern Ghana [PDF]

, 2001
Meningococcal disease remains a major public health concern, especially in the African Meningitis Belt where large meningitis epidemics with attack rates of up to 500/100,000 recur every 8-12 years.
Gagneux, Sébastien
core   +1 more source

Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?

, 2007
Background: Local immunization programs may include hexavalent and conjugate pneumococcal or meningococcal vaccines administered in the same vaccination visit.
Bartolozzi G., Aizari C., Esposito S., Giudice M. L., Fara G. M., Tozzi A. E.   +5 more
core   +1 more source

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. [PDF]

, 2015
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad.
Greenwood, Brian M, Ngadoua, C, Kadidja Gamougam, Dominique A. Caugant, Trotter, Caroline L, Toralta, J, Greenwood, B M, Ngadoua, Cyriaque, Fermon, Florence, Manigart, Olivier, Daugla, D M, Olivier Manigart, Daugla, Doumagoum M, Florence Fermon, Page, A-L, Caugant, D A, Djingarey, M H, Doumagoum M. Daugla, Fermon, F, James M. Stuart, Page, Anne-Laure, Trotter, C L, Caugant, Dominique A, Djingarey, Mamoudou H, Anne-Laure Page, Mamoudou Djingarey, Gamougam, Kadidja, Cyriaque Ngadoua, Toralta, Jacques, Stuart, J M, Stuart, James M, Gamougam, K, Manigart, O, Caroline L. Trotter, Jacques Toralta, Brian M. Greenwood   +35 more
core   +1 more source

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3

Биопрепараты: Профилактика, диагностика, лечение, 2018
Despite the progress in fighting against infectious diseases of bacterial origin, the incidence of generalized forms of meningococcal infection (GFMI) remains a topical public health problem not only in countries with historical high incidence, but also ...
M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya   +2 more
doaj  

What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? [PDF]

, 2011
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings.
Heuberger, S., Stuart, J.M., G. HANQUET, Nielsen, Stine, Stefanoff, P., P. STEFANOFF, Hanquet, G, Hanquet, Germaine, S. HEUBERGER, Nielsen, S, J. M. STUART, W. HELLENBRAND, Stefanoff, P, Stuart, JM, Hellenbrand, Wiebke, Heuberger, S, S. NIELSEN, Hellenbrand, W, Hanquet, G.   +18 more
core   +1 more source

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

Infection and Drug Resistance, 2014
Carine P Hedari,* Rima W Khinkarly,* Ghassan S Dbaibo Center for Infectious Diseases Research, Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon ...
Hedari CP, Khinkarly RW, Dbaibo GS
doaj